Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Suzanne Bertisch
Acute sleep rebound following sleep restriction is associated with reduced mortality risk
Abstract Public health guidelines recommend 7–9 hours of regular sleep and suggest weekend catch-up sleep after weekday sleep deficits. However, real-world sleep patterns are more complex than laboratory-studied models or simple weekday-weekend cycles. Epidemiological evidence on the necessity of acute rebound after restriction remains limited.
Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiology
Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiology Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. View Full Text Read the full text or download the PDF: Read the full text or download the PDF:
Obstructive sleep apnea mediates genetic risk of Diabetes Mellitus: The Hispanic Community Health Study/Study of Latinos
Dr. Redline discloses consulting relationships with Eli Lilly Inc. Additionally, Dr. Redline serves as an unpaid member of the Apnimed Scientific Advisory Board, as an unpaid board member for the Alliance for Sleep Apnoea Partners and for the National Sleep Foundation.
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
CONFLICT OF INTEREST STATEMENT Dr. Suzanne M. Bertisch may have a perceived conflict of interest given consultant work with Idorsia, who developed a novel insomnia pharmacotherapy, and ResMed, which sells devices to treat sleep apnea. Maggie R. Mittleman, Elizabeth Mostofsky, and Angeliki Vgontzas declare no other direct or perceived conflict interests related to this work. REFERENCES 1, , , , , .
Do Insomnia Treatments Improve Daytime Function?
Open AccessArticle by Nathaniel F. Watson 1,*, Suzanne M. Bertisch 2, Charles M. Morin 3, Rafael Pelayo 4, John W. Winkelman 5,6, Phyllis C. Zee 7 and Andrew D.
Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal
Open AccessReview by 1,*, 2, 3, 4, 5 and 6 1 Department of Psychiatry and Behavioral Sciences, Stanford University Sleep Medicine Center, Redwood City, CA 94063, USA 2 Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA 3 Department of Psychology, Cervo Brain Research Centre, Laval University, Quebec, QC G1E 1T2, Canada 4 Department of Psychiatry and Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 5 Department of Neurology,...
Wake Up America: National Survey of Patients’ and Physicians’ Views and Attitudes on Insomnia Care
4. Discussion According to the American Heart Association, this first large-scale survey of PWTS and HCPs provided evidence that both groups agreed on the importance of sleep, an essential component of cardiovascular health [16]. In addition, the majority of PWTS, PCPs, and psychiatrists agreed with the characterization that sleep should be considered a key pillar of health.
What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?
Open AccessReview by Charles M. Morin 1,*, Suzanne M. Bertisch 2, Rafael Pelayo 3, Nathaniel F. Watson 4, John W. Winkelman 5, Phyllis C. Zee 6 and Andrew D.
Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence
Abstract : While evidence supports the benefits of medications for the treatment of chronic insomnia, there is ongoing debate regarding their appropriate duration of use. A panel of sleep experts conducted a clinical appraisal regarding the use of insomnia medications, as it relates to the evidence supporting the focus statement, “No insomnia medication should be used on a daily basis for durations longer than 3 weeks at a time”.
Cognitive behavioral therapy for insomnia by telemedicine: Is it as good as in-person treatment?
Chronic insomnia, characterized by dissatisfaction in sleep quality or duration, is a common health problem affecting an estimated 10% to 15% of US adults. Cognitive behavioral therapy for insomnia, or CBTi, is considered first-line treatment for insomnia. CBTi, often misrepresented as talk therapy or sleep hygiene, involves both behavioral and cognitive therapy to treat insomnia.
Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine
RESEARCH SUBMISSIONS Murray A. Mittleman MD, DrPH Corresponding Author mmittlem@hsph.harvard.edu orcid.org/https://orcid.org/0000-0001-9788-7274 Department of Epidemiology, Harvard University T.H. Chan School of Public Health, Boston, MA, USA Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA Correspondence Murray A.
Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018
In 2012, 19% of US adults reported regular insomnia or sleeping problems.1 Medications most commonly used for insomnia are zolpidem (a benzodiazepine receptor agonist) and trazodone (a sedating antidepressant used in low doses for insomnia).2 Prescriptions for these drugs increased during the 1990s and early 2000s,2,3 but recent trends have not been adequately described.
Strategies to promote better sleep in these uncertain times
Sleep April 4, 2020 By Suzanne Bertisch, MD, MPH, Contributor These are unprecedented times. Given the real and tangible threat of the coronavirus pandemic on personal, community, and societal levels, it is normal to experience anxiety and sleep problems.
Coronavirus Resource Center
As coronavirus continues to spread, many questions and answers Below, you'll find answers to common questions all of us are asking. We will be adding new questions and updating answers as reliable information becomes available. Also see our blog posts featuring experts discussing coronavirus and COVID-19 and our glossary for relevant terms. New questions and answers When will children be able to get the COVID-19 vaccine?
Sleep driving and other unusual practices during sleep - Harvard Health Blog
Home » Harvard Health Blog » Sleep driving and other unusual practices during sleep - Harvard Health Blog Most people have talked or walked during sleep at some time in our lives. However, some people exhibit more unusual complex behaviors while asleep, including eating and driving. These types of behaviors, called parasomnias, come about when parts of our brain are asleep and other parts awake at the same time.
No more counting sheep: Proven behaviors to help you sleep - Harvard Health Blog
Home » Harvard Health Blog » No more counting sheep: Proven behaviors to help you sleep - Harvard Health Blog As humans, we spend about one-third of our lives asleep. Though science has taught us about the human brain’s exquisite control of our daily sleep and wake patterns, tens of millions of Americans still don’t get the sleep they need. Nearly 20% of American adults report using a sleep medication to help them sleep, despite known side effects and information about how well they really work.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Suzanne
Contact Suzanne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack